U.S. veterans experiencing cirrhosis, or damage to the liver, and who also received an mRNA COVID-19 vaccine saw high levels of protection against virus-related hospitalization and death, a study found.
U.S. veterans experiencing cirrhosis, or damage to the liver, and who also received an mRNA COVID-19 vaccine saw high levels of protection against virus-related hospitalization and death, a study found.